Notice2024-03783
Draft Infection Control in Healthcare Personnel: Epidemiology and Control of Selected Infections Transmitted Among Healthcare Personnel and Patients: Cytomegalovirus and Parvovirus B19 Sections and Draft Source Control Definition
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 26, 2024
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), in the Department of Health and Human Services (HHS), announces the opening of a docket to obtain comment on the Draft Infection Control in Healthcare Personnel: Epidemiology and Control of Selected Infections Transmitted Among Healthcare Personnel and Patients: Cytomegalovirus and Parvovirus B19 Sections ("Draft Guideline: Cytomegalovirus and Parvovirus B19 Sections"), and on the accompanying Draft "Source Control" Definition adapted for Infection Control in Healthcare Personnel to be in the "Terminology" Appendix. The updated recommendations in the Draft Guideline: Cytomegalovirus and Parvovirus B19 Sections are intended for use by the leaders and staff of Occupational Health Services (OHS), as further provided herein. These updated recommendations will help facilitate the provision of occupational infection prevention and control services to healthcare personnel (HCP) who have been exposed or infected and may be contagious to others in the workplace.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 38 (Monday, February 26, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 38 (Monday, February 26, 2024)]
[Notices]
[Pages 14075-14076]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-03783]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2024-0014]
Draft Infection Control in Healthcare Personnel: Epidemiology and
Control of Selected Infections Transmitted Among Healthcare Personnel
and Patients: Cytomegalovirus and Parvovirus B19 Sections and Draft
Source Control Definition
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), in the
Department of Health and Human Services (HHS), announces the opening of
a docket to obtain comment on the Draft Infection Control in Healthcare
Personnel: Epidemiology and Control of Selected Infections Transmitted
Among Healthcare Personnel and Patients: Cytomegalovirus and Parvovirus
B19 Sections (``Draft Guideline: Cytomegalovirus and Parvovirus B19
Sections''), and on the accompanying Draft ``Source Control''
Definition adapted for Infection Control in Healthcare Personnel to be
in the ``Terminology'' Appendix. The updated recommendations in the
Draft Guideline: Cytomegalovirus and Parvovirus B19 Sections are
intended for use by the leaders and staff of Occupational Health
Services (OHS), as further provided herein. These updated
recommendations will help facilitate the provision of occupational
infection prevention and control services to healthcare personnel (HCP)
who have been exposed or infected and may be contagious to others in
the workplace.
DATES: Written comments must be received on or before April 26, 2024.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2024-
0014 by either of the methods listed below. Do not submit comments by
email. CDC does not accept comments by email.
<bullet> Federal eRulemaking Portal: <a href="http://www.regulations.gov">http://www.regulations.gov</a>.
Follow the instructions for submitting comments.
<bullet> Mail: Healthcare Infection Control Practices Advisory
Committee (HICPAC) Secretariat, Division of Healthcare Quality
Promotion, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, Mailstop H16-3, Atlanta, Georgia 30329, Attn: Docket Number
CDC-2024-0014.
Instructions: All submissions received must include the agency name
and Docket Number. All relevant comments received will be posted
without change to <a href="http://regulations.gov">http://regulations.gov</a>, including any personal
information provided. For access to the docket to read background
documents or comments received, go to <a href="http://www.regulations.gov">http://www.regulations.gov</a>.
FOR FURTHER INFORMATION CONTACT: Laura Wells, Division of Healthcare
Quality Promotion, Centers for Disease Control and Prevention, 1600
Clifton Road NE, Mailstop H16-2, Atlanta, Georgia 30329; Telephone:
(404) 639-4000.
SUPPLEMENTARY INFORMATION:
Public Participation
Interested persons or organizations are invited to participate by
submitting written views, recommendations, and data related to the
Draft Guideline: Cytomegalovirus and Parvovirus B19 Sections, and the
accompanying Draft ``Source Control'' Definition.
Please note that comments received, including attachments and other
supporting materials, are part of the public record and are subject to
public disclosure. Comments will be posted on <a href="https://www.regulations.gov">https://www.regulations.gov</a>. Therefore, do not include any information in your
comment or supporting materials that you consider confidential or
inappropriate for public disclosure. If you include your name, contact
information, or other information that identifies you in the body of
your comments, that information will be on public display. CDC will
review all submissions and may choose to redact, or withhold,
submissions containing private or proprietary information such as
Social Security numbers, medical information, inappropriate language,
or duplicate/near duplicate examples of a mass-mail campaign. Do not
submit comments by email. CDC does not accept comments by email.
Background
The Draft Guideline: Cytomegalovirus and Parvovirus B19 Sections,
located in the ``Supporting & Related Material'' tab of the docket,
updates the Guideline for infection control in health care personnel,
1998, Part E: Epidemiology and Control of Selected Infections
Transmitted Among Health Care Personnel and Patients, and its
corresponding recommendations in Part II of the 1998 Guideline: ``3.
Cytomegalovirus;'' and ``11. Parvovirus.'' The accompanying Draft
``Source Control'' Definition adapted for Infection Control in
Healthcare Personnel to be in the ``Terminology'' Appendix (<a href="https://www.cdc.gov/infectioncontrol/guidelines/healthcare-personnel/terminology.html">https://www.cdc.gov/infectioncontrol/guidelines/healthcare-personnel/terminology.html</a>) is also located in the ``Supporting & Related
Material'' tab of the docket. The 1998 Guideline provided information
and recommendations for Occupational Health Services (OHS) of
healthcare facilities and systems on the prevention of transmission of
infectious diseases among healthcare personnel (HCP) and patients and
can be found at <a href="https://stacks.cdc.gov/view/cdc/11563">https://stacks.cdc.gov/view/cdc/11563</a>.
As described in the Executive Summary of this guideline (<a href="https://www.cdc.gov/infectioncontrol/guidelines/healthcare-personnel/exec-summary.html">https://www.cdc.gov/infectioncontrol/guidelines/healthcare-personnel/exec-summary.html</a>), in this document, ``OHS'' is used synonymously with
``Employee Health,'' ``Employee Health Services,'' ``Employee Health
and Safety,'' ``Occupational Health,'' and other such programs. OHS
refers to the
[[Page 14076]]
group, department, or program that addresses many aspects of health and
safety in the workplace for HCP, including the provision of clinical
services for work-related injuries, exposures, and illnesses. In
healthcare settings, OHS addresses workplace hazards including
communicable diseases; slips, trips, and falls; patient-handling
injuries; chemical exposures; HCP burnout; and workplace violence.
This Draft Guideline: Cytomegalovirus and Parvovirus B19 Sections
update is part of a larger guideline update: Infection Control in
Healthcare Personnel. Part I, Infrastructure and Routine Practices for
Occupational Infection Prevention and Control Services (2019), and the
Diphtheria, Group A Streptococcus, Meningococcal Disease, Pertussis,
and Rabies sections of Part II, Epidemiology and Control of Selected
Infections Transmitted Among Healthcare Personnel and Patients (2022)
are complete and have been published on the CDC Infection Control
Guideline website: <a href="https://www.cdc.gov/infectioncontrol/guidelines/healthcare-personnel/index.html">https://www.cdc.gov/infectioncontrol/guidelines/healthcare-personnel/index.html</a>. The Draft Guideline: Cytomegalovirus
and Parvovirus B19 Sections, once finalized, is intended for use by the
leaders and staff of OHS to guide the management of exposed or infected
HCP who may be contagious to others in the workplace. The draft
recommendations in Draft Guideline: Cytomegalovirus and Parvovirus B19
Sections update the 1998 recommendations with current guidance on the
management of HCP exposed to or potentially infected with
cytomegalovirus or parvovirus B19, focusing on postexposure management,
including postexposure prophylaxis, for exposed HCP and work
restrictions for exposed or infected HCP. The adapted Draft ``Source
Control'' Definition is being added to the ``Terminology'' Appendix of
the Infection Control in Healthcare Personnel Guideline (<a href="https://www.cdc.gov/infectioncontrol/guidelines/healthcare-personnel/terminology.html">https://www.cdc.gov/infectioncontrol/guidelines/healthcare-personnel/terminology.html</a>) because the term ``Source Control'' is used in the
Draft Guideline: Parvovirus B19 Section, and may be used in subsequent
sections.
Since 2015, the Healthcare Infection Control Practices Advisory
Committee (HICPAC) has worked with national partners, academicians,
public health professionals, healthcare providers, and other partners
to develop Infection Control in Healthcare Personnel (<a href="https://www.cdc.gov/infectioncontrol/guidelines/healthcare-personnel/index.html">https://www.cdc.gov/infectioncontrol/guidelines/healthcare-personnel/index.html</a>) as a segmental update of the 1998 Guideline. HICPAC is a
Federal advisory committee appointed to provide advice and guidance to
HHS and CDC regarding the practice of infection control and strategies
for surveillance, prevention, and control of healthcare-associated
infections, antimicrobial resistance, and related events in United
States healthcare settings. HICPAC includes, but is not limited to,
representatives with expertise in public health, infectious diseases,
and infection prevention and control. HICPAC also includes ex officio
members who represent regulatory and other Federal agencies, and
liaison representatives from professional societies. Draft Guideline:
Cytomegalovirus and Parvovirus B19 Sections, once finalized, will be
the next sections to be posted to the Infection Control in Healthcare
Personnel website. The accompanying Draft ``Source Control'' Definition
will be added to the Infection Control in Healthcare Personnel
``Terminology'' Appendix (<a href="https://www.cdc.gov/infectioncontrol/guidelines/healthcare-personnel/terminology.html">https://www.cdc.gov/infectioncontrol/guidelines/healthcare-personnel/terminology.html</a>).
The updated draft recommendations in Draft Guideline:
Cytomegalovirus and Parvovirus B19 Sections are informed by reviews of
the 1998 Guideline; CDC resources (e.g., CDC infection control
website), infection control guidance, and guidelines, as noted more
specifically in the draft document; and new scientific evidence, when
available. CDC is seeking comments on the Draft Guideline:
Cytomegalovirus and Parvovirus B19 Sections and the accompanying Draft
``Source Control'' Definition. Please provide references to new
evidence and justification to support any suggested revisions or
additions. This Draft Guideline: Cytomegalovirus and Parvovirus B19
Sections and the accompanying Draft ``Source Control'' Definition are
not Federal rules or regulations.
Noah Aleshire,
Chief Regulatory Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-03783 Filed 2-23-24; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on February 26, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.